India’s Eris Lifesciences launches generic semaglutide at $13.8 per month
- ByInvesting.com-
Investing.com -- India’s Eris Lifesciences launched one of the most affordable versions of generic semaglutide on Friday, with the...
Last | High | Low | |||||
|---|---|---|---|---|---|---|---|
| 2,195.25 | 2,224.00 | 2,185.50 | +8.70 | +0.40% | 36.89K | ||
| 1,204.25 | 1,231.25 | 1,200.00 | -2.40 | -0.20% | 195.93K | ||
| 830.40 | 839.00 | 819.55 | -1.60 | -0.19% | 562.12K | ||
| 1,709.75 | 1,733.95 | 1,702.95 | -2.90 | -0.17% | 149.85K | ||
| 1,846.50 | 1,861.00 | 1,835.00 | +17.35 | +0.95% | 261.07K | ||
| 1,334.05 | 1,352.75 | 1,329.40 | +22.70 | +1.73% | 56.35K | ||
| 780.45 | 794.00 | 778.60 | -19.25 | -2.41% | 5.03M | ||
| 2,083.90 | 2,100.00 | 2,068.90 | +6.45 | +0.31% | 76.66K | ||
| 1,245.55 | 1,274.10 | 1,241.40 | -5.25 | -0.42% | 948.23K | ||
| 819.95 | 836.70 | 813.00 | +3.65 | +0.45% | 95.32K | ||
| 1,254.60 | 1,264.00 | 1,229.30 | +33.95 | +2.78% | 324.04K | ||
| 299.90 | 308.60 | 298.15 | +1.85 | +0.62% | 1.86M | ||
| 366.95 | 372.60 | 365.60 | -1.00 | -0.27% | 594.21K | ||
| 3,434.80 | 3,523.85 | 3,409.05 | -0.45 | -0.01% | 148.51K | ||
| 3,065.30 | 3,105.00 | 3,044.50 | +19.70 | +0.65% | 181.71K | ||
| 12,602.65 | 12,754.05 | 12,559.90 | +11.20 | +0.09% | 20.39K | ||
| 1,365.10 | 1,393.60 | 1,358.95 | +9.30 | +0.69% | 92.29K | ||
| 380.80 | 383.45 | 375.70 | +6.85 | +1.83% | 637.28K | ||
| 297.50 | 304.85 | 296.65 | +0.90 | +0.30% | 225.44K | ||
| 1,414.55 | 1,430.00 | 1,395.75 | +29.20 | +2.11% | 1.13M | ||
| 1,058.40 | 1,085.00 | 1,054.05 | +9.45 | +0.90% | 778.18K | ||
| 1,777.45 | 1,781.60 | 1,755.00 | +33.10 | +1.90% | 16.23K | ||
| 2,390.60 | 2,407.80 | 2,364.00 | +34.05 | +1.44% | 188.53K | ||
| 314.15 | 316.65 | 310.05 | +4.95 | +1.60% | 373.44K | ||
| 196.70 | 199.40 | 193.20 | +6.15 | +3.23% | 2.44M | ||
| 1,384.90 | 1,390.20 | 1,342.30 | +45.15 | +3.37% | 33.79K | ||
| 4,108.20 | 4,149.55 | 4,040.00 | +72.50 | +1.80% | 93.2K | ||
| 10,927.75 | 10,975.00 | 10,860.00 | +116.75 | +1.08% | 11.56K | ||
| 1,193.90 | 1,201.75 | 1,177.75 | +5.70 | +0.48% | 40.28K | ||
| 232.30 | 236.75 | 230.50 | +3.40 | +1.49% | 2.01M |
Investing.com -- India’s Eris Lifesciences launched one of the most affordable versions of generic semaglutide on Friday, with the...
Investing.com-- Asian stocks were mixed in choppy trading on Friday, as investors grappled with sharply volatile oil prices driven...
As traders approach the final session of the trading week, a series of industry indicators and positioning reports that could...
The tape is split again. The Dow Jones Industrial Average (^DJI) trades near 49,500–49,600, up about 0.6–0.7%, driven...
Tesla is rapidly closing in on its all-time high of $479.86, achieved mid-December 2024 following Trump’s electoral victory....
U.S. equities opened sharply divided on Thursday, with the S&P 500 and Nasdaq Composite (^IXIC) giving back a chunk of...
No Earning Reports have been scheduled